News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-14 11:35:26 am KalVista: Positive Results From Phase 3 Trial Pave The Way For Commercialization (Downgrade) SeekingAlpha
2024-01-26 3:50:0 am Pharvaris to Present at the WSAAI Annual Meeting 2024 GlobeNewswire
2024-01-23 6:34:0 am Pharvaris (PHVS) Up as FDA Lifts Clinical Hold on HAE Program Zacks
2024-01-22 1:7:29 pm Top-Notch Pharvaris Eyes Profit-Taking Zone On A Key FDA Decision Investor's Business Daily
2024-01-22 3:50:0 am Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks GlobeNewswire
2024-01-05 3:50:0 am Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities GlobeNewswire
2023-12-11 3:56:4 am Pharvaris N.V.'s (NASDAQ:PHVS) largest shareholders are private equity firms who were rewarded as market cap surged US$578m last week Simply Wall St.
2023-12-08 3:0:0 pm Pharvaris Presents Deucrictibant Clinical Data and Analysis of Endpoints for Trials of On-demand Treatment of HAE at the GA²LEN UCARE Conference 2023 GlobeNewswire
2023-12-07 12:17:0 pm Pharvaris (PHVS) Stock Up 18% on HAE Drug Meeting Study Goal Zacks
   

Please consider a small donation if you think this website provides you with relevant information